Filter
12376
Filtered Results: 12376
Text search:
Treatment
Featured
Recommendations
1022
New Publications
3116
Language
Document type
No document type
7144
Studies & Reports
1793
Guidelines
1468
Manuals
523
Fact sheets
424
Strategic & Response Plan
347
Training Material
201
Situation Updates
177
Infographics
85
Resource Platforms
83
Brochures
55
Online Courses
36
Videos
34
Dashboards/Maps
3
App
3
Countries / Regions
India
578
Global
517
Kenya
326
South Africa
270
Sierra Leone
262
Liberia
256
Western and Central Europe
237
Ethiopia
228
Nigeria
223
Uganda
219
Nepal
212
Africa
176
Latin America and the Carribbean
170
Bangladesh
167
Myanmar / Burma
165
Tanzania
163
Malawi
163
Zambia
157
Rwanda
152
Syria
138
Ukraine
134
Ghana
132
Congo, Democratic Republic of
125
Namibia
103
Indonesia
101
Eastern Europe
96
Philippines
94
Russia
92
Germany
87
Zimbabwe
86
South Sudan
85
Guinea
84
Mozambique
83
Senegal
79
Lesotho
77
Brazil
75
Haiti
70
Yemen
70
West and Central Africa
67
Cambodia
66
South–East Asia Region
65
Burkina Faso
62
East and Southern Africa
60
Venezuela
59
Asia
58
Middle East and North Africa
56
Botswana
51
Colombia
43
Cameroon
40
Eswatini/ Swaziland
40
Eastern Europe and Central Asia
36
Paraguay
36
Madagascar
34
Sudan
29
Benin
29
Pakistan
28
Afghanistan
28
Mali
26
Argentina
26
USA
25
Lebanon
24
Central African Republic
23
Peru
21
Somalia
20
Jordan
20
Thailand
20
Vietnam
20
Bolivia
18
Angola
18
Western Pacific Region
18
Iraq
17
Tajikistan
17
Côte d’Ivoire / Ivory Coast
16
China
16
Ecuador
16
Chile
16
Albania
16
Moldova
15
Georgia
14
Guinea-Bissau
13
North America
13
Papua New Guinea
12
Southern Africa
12
Niger
11
Spain
11
Turkey
10
North Macedonia
10
Sri Lanka
10
Laos
10
Mexico
9
Armenia
9
Iran
9
Togo
8
Chad
8
Burundi
8
Palestine
8
Romania
8
Kyrgyzstan
8
United Kingdom
8
Malaysia
7
Greece
7
Libya
7
Poland
7
Estonia
7
Saudi Arabia
6
Egypt
6
Gambia
6
Hungary
6
El Salvador
6
Bhutan
6
Morocco
5
Serbia
5
Canada
5
Timor Leste/ East Timor
5
Uzbekistan
5
Kazakhstan
5
Jamaica
5
Belarus
5
Fiji
4
Italy
4
Japan
4
Portugal
4
Singapore
3
Switzerland
3
Djibouti
3
Mongolia
3
Turkmenistan
3
Mauritius
3
Azerbaijan
3
Mauritania
2
Croatia
2
Honduras
2
Nicaragua
2
Other region
2
North Korea
2
Qatar
2
Bulgaria
2
Lithuania
2
Slovakia
2
Gabon
2
France
2
Tunisia
2
Ireland
1
Vanuatu
1
Dominican Republic
1
Austria
1
Guatemala
1
Bahamas
1
Solomon Islands
1
Australia
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
South Korea
1
French Guyana
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
4538
Clinical Guidelines
1004
Public Health
653
Women & Child Health
567
Key Resources
403
Capacity Building
281
Pharmacy & Technologies
102
Annual Report MEDBOX
3
Toolboxes
Mental Health
1111
HIV
1067
COVID-19
1018
TB
848
Ebola
470
NTDs
412
NCDs
386
AMR
360
Disability
336
Caregiver
321
Rapid Response
308
Conflict
300
Refugee
267
Planetary Health
232
Pharmacy
222
Natural Hazards
135
Cholera
127
Global Health Education
124
Health Financing Toolbox
88
Zika
81
Specific Hazards
79
Social Ethics
49
Polio
41
Typhoon
6
South Sudan
2
Health Financing
2
Unstable settings present challenges for the effective provision of antiretroviral treatment (ART). In this paper, we summarize the experience and results of providing ART and implementing contingency plans during acute instability in the Central Af...
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
Antimicrobial resistance has become a serious public health threat for effective treatment of an ever increasing range of infections caused by bacteria, parasites, viruses and fungi. When infections can no longer be treated by first-line antibiotics...
AWaRe – a new WHO tool to help countries improve antibiotic treatment, increase access and reduce resistance. We can reduce or even reverse antibiotic resistance by using antibiotics more responsibly. But how do we do that and still ensure that pa...
The outbreak of the coronavirus is leading to increased challenges in clinical management and uncertainty among the general population. To support the advice and treatment of patients, we have updated our Knowledge Library to include an informative ...
Solidarity” is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners.
The Solidarity Trial will compare four treatmen... options against standard of care, to assess their relative effectiveness against COVID-19. By enrolling patients in multiple countries, the Solidarity Trial aims to rapidly discover whether any of the drugs slow disease progression or improve survival. Other drugs can be added based on emerging evidence.
Until there is sufficient evidence, WHO cautions against physicians and medical associations recommending or administering these unproven treatments to patients with COVID-19 or people self-medicating with them. WHO is concerned by reports of individuals self-medicating with chloroquine and causing themselves serious harm.
Africa Centers for Disease Control and Prevention (Africa CDC) is aware of the media releases of the preliminary results of a large randomized clinical trial conducted in the United Kingdom, which included dexamethasone, a corticosteroid, as one of the drugs used for the ... of COVID-19 patients. The investigators reported that administration of oral or injectable dexamethasone resulted in about one-third reduction in mortality among COVID-19 patientsi that required mechanical ventilation and about one-fifth for patients requiring oxygen.
Web annex 6: Injectable prostaglandins versus
placebo or no treatment
Evidence to Decision Framework
Web annex 5: Oxytocin and ergometrine versus placebo or no treatment
Evidence to decision framework
Web annex 2: Carbetocin versus placebo or no treatment
Evidence to decision framework
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not t...
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and ... of COVID-19 by the public in African Union Member States.
Currently, there is:
1. No scientific evidence from pre-clinical studies on the therapeutic effect of ivermectin for the management of COVID-19;
2. No evidence of its clinical efficacy for the management of patients with asymptomatic, mild, moderate or severe COVID-19; and
3. No safety data regarding the use of ivermectin for COVID-19 in the majority of the published studies.
Medical oxygen is an essential medicine in the treatment of COVID-19. How is it used? Why is there a shortage in some countries and what are WHO, partners and Governments doing about it? WHO’s Dr Janet Diaz explains in Science in 5.
Practical guide on patient education on the effectiveness of Pulmonary Tuberculosis treatment at Salasaca Health Centre
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Global and Regional Data 1 December 2021; The 90–90–90 targets were missed, but not by much. At the end of 2020, 84% of people living with HIV knew their HIV status, 87% of people living with HIV who knew their HIV status were accessing antiretroviral therapy, and 90% of people on ... were virally suppressed.
Consensual recommendations for outpatient management and home care
and home treatment of patients with COVID-19
Antimicrobial Resistance Resource Platform
recommended
Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.
AMR occurs when bacteria, viruses, fungi and parasites change over time and ...
Protocol for the management of specialized centres for the treatment of people with alcohol and other drug abuse problems (CETAD) in the framework of the COVID-19 pandemic. Version 1.
For 100 cases among which 60 cases of children ≥ 5 years old and 40 cases of children < 5 years old and adults.
The new Pneumonia kit 2020 is specially designed to provide sufficient child-size antibiotics to treat pneumonia, targeting children under 5 years of age. It aims to provide life-savi...
